EdgarLookup

Edgewise Therapeutics, Inc. — All Filings

372 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-Q 144 3 4 424B3 424B4 424B5 8-A12B 8-K ARS CERT CORRESP D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT PRE 14A S-1 S-1/A S-1MEF S-3 S-3ASR S-3MEF S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
144 0001950047-26-003048 Mar 27, 2026
10-K 10-K 0001104659-26-020112 Feb 26, 2026 Dec 31, 2025
8-K FORM 8-K 0001104659-26-020108 Feb 26, 2026
SCHEDULE 13G/A 0001104659-26-016362 Feb 17, 2026
4 PRIMARY DOCUMENT 0001786966-26-000001 Jan 23, 2026 Jan 21, 2026
144 0001968582-26-000043 Jan 21, 2026
144 0001950047-26-000548 Jan 20, 2026
144 0001950047-26-000490 Jan 15, 2026
4 PRIMARY DOCUMENT 0001655016-26-000001 Jan 5, 2026 Jan 2, 2026
144 0001950047-25-010707 Dec 29, 2025
4 PRIMARY DOCUMENT 0002097992-25-000005 Nov 24, 2025 Nov 19, 2025
3 PRIMARY DOCUMENT 0002097992-25-000004 Nov 24, 2025 Nov 19, 2025
8-K FORM 8-K 0001104659-25-114660 Nov 20, 2025 Nov 19, 2025
144 0001950047-25-008981 Nov 17, 2025
SCHEDULE 13G/A 0001231919-25-000488 Nov 14, 2025
4 PRIMARY DOCUMENT 0001853529-25-000007 Nov 13, 2025 Nov 12, 2025
4 PRIMARY DOCUMENT 0001655016-25-000007 Nov 13, 2025 Nov 11, 2025
4 PRIMARY DOCUMENT 0001705477-25-000005 Nov 13, 2025 Nov 10, 2025
3 PRIMARY DOCUMENT 0001705477-25-000004 Nov 13, 2025 Nov 10, 2025
144 0001950047-25-008795 Nov 12, 2025
8-K FORM 8-K 0001104659-25-109295 Nov 10, 2025
10-Q 10-Q 0001104659-25-107427 Nov 6, 2025 Sep 30, 2025
8-K FORM 8-K 0001104659-25-107419 Nov 6, 2025
4 PRIMARY DOCUMENT 0001655016-25-000004 Oct 2, 2025 Oct 1, 2025
4 PRIMARY DOCUMENT 0001853529-25-000003 Aug 28, 2025 Aug 26, 2025
144 0001950047-25-006390 Aug 26, 2025
4 PRIMARY DOCUMENT 0001562180-25-005800 Aug 14, 2025 Aug 12, 2025
4 PRIMARY DOCUMENT 0001562180-25-005799 Aug 14, 2025 Aug 12, 2025
4 PRIMARY DOCUMENT 0001562180-25-005798 Aug 14, 2025 Aug 12, 2025
4 PRIMARY DOCUMENT 0001562180-25-005797 Aug 14, 2025 Aug 12, 2025
4 PRIMARY DOCUMENT 0001562180-25-005796 Aug 14, 2025 Aug 12, 2025
4 PRIMARY DOCUMENT 0001562180-25-005795 Aug 14, 2025 Aug 12, 2025
4 PRIMARY DOCUMENT 0001562180-25-005794 Aug 14, 2025 Aug 12, 2025
SCHEDULE 13G/A 0001104659-25-078659 Aug 14, 2025
SCHEDULE 13G/A 0000950170-25-108936 Aug 14, 2025
10-Q 10-Q 0001558370-25-010655 Aug 7, 2025 Jun 30, 2025
8-K FORM 8-K 0001104659-25-074987 Aug 7, 2025
SCHEDULE 13G/A 0002052113-25-003023 Jul 17, 2025
4 PRIMARY DOCUMENT 0001562180-25-005233 Jul 2, 2025 Jul 1, 2025
8-K FORM 8-K 0001104659-25-063028 Jun 26, 2025
4 PRIMARY DOCUMENT 0001562180-25-004961 Jun 18, 2025 Jun 16, 2025
4 PRIMARY DOCUMENT 0001562180-25-004960 Jun 18, 2025 Jun 16, 2025
4 PRIMARY DOCUMENT 0001562180-25-004959 Jun 18, 2025 Jun 16, 2025
4 PRIMARY DOCUMENT 0001562180-25-004958 Jun 18, 2025 Jun 16, 2025
4 PRIMARY DOCUMENT 0001562180-25-004957 Jun 18, 2025 Jun 16, 2025
4 PRIMARY DOCUMENT 0001562180-25-004956 Jun 18, 2025 Jun 16, 2025
SCHEDULE 13G/A 0000950170-25-072730 May 15, 2025
DEFA14A DEFA14A 0001104659-25-048504 May 14, 2025
SCHEDULE 13D/A 0000947871-25-000490 May 12, 2025
10-Q 10-Q 0001558370-25-006857 May 8, 2025 Mar 31, 2025